Travere Therapeutics, Inc. · NASDAQ:TVTX
Poole Sandra received 4,000 Travere Therapeutics, Inc. shares as an award (Form 4)
Traded May 19, 2026 · Filed May 21, 2026
On May 19, 2026, Poole Sandra (Director) received 4,000 Travere Therapeutics, Inc. shares as an award, leaving 34,000 shares. Filed May 21, 2026 (Form 4).
- Awarded
- 4,000 shares
- Holding after
- 34,000 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 19, 2026 | Common Stock | Award | 4,000 | 34,000 | Direct |